Cardiac consequences of hypertension in hemodialysis patients.
作者： Carmine Zoccali , Francesco Antonio Benedetto , Giovanni Tripepi , Francesca Mallamaci
DOI: 10.1111/J.0894-0959.2004.17331.X
关键词:
摘要: Hypertension in end-stage renal disease (ESRD) is an important risk factor for left ventricular hypertrophy (LVH), cardiac failure, coronary artery (CAD), and arrhythmia. LVH generally considered integrator of the long-term effects hypertension other cardiovascular (CV) factors represents strongest predictor adverse CV outcomes ESRD patients. The heart failure higher patients with a history hypertensive than those diagnoses. Both (CHD) predict congestive which often ultimate cause death ischemia or LVH. A long-standing associated ischemic both cross-sectional prospective studies ESRD. Atrial fibrillation arrhythmias are highly prevalent dialysis implicated mortality sudden this population. Despite lack evidence from randomized controlled trials, it appears reasonable that interventions aimed at curbing high should be targeted to
sci-hub.se 参考文章(52)
Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. The Lancet. ,vol. 360, pp. 1903- 1913 ,(2002) , 10.1016/S0140-6736(02)11911-8
Carmine Zoccali, Francesca Mallamaci, Giovanni Tripepi, Frank A Benedetto, Emilio Cottini, Giuseppe Giacone, Lorenzo Malatino, CREED investigators, Prediction of left ventricular geometry by clinic, pre-dialysis and 24-h ambulatory BP monitoring in hemodialysis patients Journal of Hypertension. ,vol. 17, pp. 1751- 1758 ,(1999) , 10.1097/00004872-199917120-00013
Gennaro Cice, Luigi Ferrara, Antonello D’Andrea, Salvatore D’Isa, Attilio Di Benedetto, Antonio Cittadini, Pina Elvira Russo, Paolo Golino, Raffaele Calabrò, Carvedilol increases two-year survivalin dialysis patients with dilated cardiomyopathy: A prospective, placebo-controlled trial Journal of the American College of Cardiology. ,vol. 41, pp. 1438- 1444 ,(2003) , 10.1016/S0735-1097(03)00241-9
Gruppo Emodialisi E Patologie Cardiovascolari, MULTICENTRE, CROSS-SECTIONAL STUDY OF VENTRICULAR ARRHYTHMIAS IN CHRONICALLY HAEMODIALYSED PATIENTS The Lancet. ,vol. 332, pp. 305- 309 ,(1988) , 10.1016/S0140-6736(88)92357-4
Pietro Patrone, Davide Rolla, Giuseppe Cannella, Ernesto Paoletti, Sergio Barocci, Fabio Massarino, Roberto Delfino, Giambattista Ravera, Giovanni Di Maio, Arcangelo Nocera, Angiotensin-converting enzyme gene polymorphism and reversibility of uremic left ventricular hypertrophy following long-term antihypertensive therapy. Kidney International. ,vol. 54, pp. 618- 626 ,(1998) , 10.1046/J.1523-1755.1998.00027.X
Naheed Ansari, Thomas Manis, Donald A. Feinfeld, Symptomatic atrial arrhythmias in hemodialysis patients. Renal Failure. ,vol. 23, pp. 71- 76 ,(2001) , 10.1081/JDI-100001285
José Jayme G. De Lima, Heno F. Lopes, César J. Grupi, Henry Abensur, Maria Clementina P. Giorgi, Eduardo M. Krieger, Fulvio Pileggi, Blood Pressure Influences the Occurrence of Complex Ventricular Arrhythmia in Hemodialysis Patients Hypertension. ,vol. 26, pp. 1200- 1203 ,(1995) , 10.1161/01.HYP.26.6.1200
Bernard Charra, Edouard Calemard, Guy Laurent, Importance of treatment time and blood pressure control in achieving long-term survival on dialysis. American Journal of Nephrology. ,vol. 16, pp. 35- 44 ,(1996) , 10.1159/000168968
Friedrich K. Port, Tempie E. Hulbert-Shearon, Robert A. Wolfe, Wendy E. Bloembergen, Thomas A. Golper, Lawrence Y.C. Agodoa, Eric W. Young, Predialysis blood pressure and mortality risk in a national sample of maintenance hemodialysis patients. American Journal of Kidney Diseases. ,vol. 33, pp. 507- 517 ,(1999) , 10.1016/S0272-6386(99)70188-5
Robert N. Foley, Charles A. Herzog, Allan J. Collins, Blood pressure and long-term mortality in United States hemodialysis patients: USRDS Waves 3 and 4 Study. Kidney International. ,vol. 62, pp. 1784- 1790 ,(2002) , 10.1046/J.1523-1755.2002.00636.X